1. Metric Overview

The Harmonic Signal Vector — Field & Frequency Metric (HSV-F²) is the SEF metric used to quantify the metabolic and energetic coherence of a therapeutic system across time, tissue context, and physiologic load.

HSV-F² evaluates whether an intervention produces a biologic effect with harmonic energetic efficiency, rather than excessive metabolic burden, redox destabilization, or incoherent temporal activity. Within the SCF principle map, HSV-F² aligns directly with Metabolic Efficiency.

Where TSSM asks whether a therapy is strong, precise, and durable, HSV-F² asks whether it is energetically coherent enough to be sustained by the living system.

2. Conceptual Rationale

A therapeutic system may show potency and specificity yet still fail translationally if it imposes excessive metabolic cost or produces oscillatory biologic stress. In SCF logic, therapeutics must not only inhibit disease pathways; they must also preserve or improve the system’s energetic order.

HSV-F² therefore evaluates synergy across two linked dimensions:

The metric is designed to capture whether therapeutic action is:

• metabolically efficient
• redox-compatible
• temporally stable
• physiologically synchronized

3. Mathematical Formulation

The base HSV-F² score is defined as:

$HSV\text{-}F^2 = H \times F_{field} \times F_{freq}$

Where:

Because the framework emphasizes dual convergence of field and frequency, the notation is written as F².

A weighted form may be used as:

$HSV\text{-}F^2 = H^{\alpha} \times F_{field}^{\beta} \times F_{freq}^{\gamma}$

Typical starting values:

$\alpha = 1,\quad \beta = 1,\quad \gamma = 1$

4. Component Definitions

4.1 Harmonic Efficiency Coefficient (H)

This term measures therapeutic output relative to metabolic cost:

$H = \frac{E_{ther}}{C_{met}}$

Where:

Higher H indicates greater therapeutic benefit per unit metabolic burden.

Metabolic cost may be estimated from ATP depletion, ROS generation, mitochondrial stress, or flux imbalance.

4.2 Field Coherence Coefficient $(F_{field})$

This term measures how consistently the therapeutic effect is distributed across relevant biologic compartments:

$F_{field} = \frac{\sum_{i=1}^{n} w_i \, S_i}{\sum_{i=1}^{n} w_i}$

Where:

$F_{field}$ approaches 1 when therapeutic signaling remains spatially coherent across intended targets without diffuse off-system disturbance.

4.3 Frequency Coherence Coefficient ($F_{freq}$)

This term measures temporal/rhythmic alignment of therapeutic effect:

$F_{freq} = 1 - \frac{\sigma_{\Delta t}}{\mu_{\Delta t} + \varepsilon}$

Where:

A higher score indicates more regular temporal behavior and less oscillatory instability.

Alternative implementations may compare therapeutic periodicity against circadian or ultradian physiologic reference rhythms.

5. Expanded HSV-F² Equation

Substituting components:

$HSV\text{-}F^2 = \left(\frac{E_{ther}}{C_{met}}\right)^{\alpha} \times \left(\frac{\sum_{i=1}^{n} w_i S_i}{\sum_{i=1}^{n} w_i}\right)^{\beta} \times \left(1 - \frac{\sigma_{\Delta t}}{\mu_{\Delta t} + \varepsilon}\right)^{\gamma}$

This form integrates therapeutic benefit, metabolic expense, spatial coherence, and temporal stability into a single energetic-synergy metric.

6. Biological Interpretation

High HSV-F² values indicate that the therapy is exerting useful biologic activity without imposing disproportionate energetic strain.

7. Experimental Measurement

HSV-F² is derived from conventional laboratory and systems-level measurements.

Harmonic Efficiency Inputs

Measured using:

• Seahorse extracellular flux analysis
• ATP/AMP ratio assays
• mitochondrial membrane potential
• ROS kinetics
• oxygen consumption rate / glycolytic balance

Field Coherence Inputs

Measured using:

• tissue-response panels
• organoid or co-culture system profiling
• biomarker mapping across compartments
• multi-tissue transcriptomic or proteomic response consistency

Frequency Coherence Inputs

Measured using:

• time-course signaling assays
• repeated biomarker sampling
• oscillation and decay kinetics
• chronobiology-aligned response mapping

These measurement concepts are consistent with the SEF laboratory implementation logic for metabolic efficiency assessment.

8. Example Calculation

Suppose a therapeutic system shows:

First:

$H = \frac{0.84}{0.42} = 2.0$

Next:

$F_{field} = 0.78$

Then:

$F_{freq} = 1 - \frac{2}{10.01} \approx 0.80$

Thus:

$HSV\text{-}F^2 = 2.0 \times 0.78 \times 0.80$

$HSV\text{-}F^2 \approx 1.25$

Interpretation: good metabolic coherence with acceptable temporal stability.

9. Role in SCF Drug Design

Within the SCF therapeutic engineering workflow, HSV-F² is used to:

• reject high-burden compounds that destabilize metabolism
• prioritize combinations with efficient energy usage
• compare formulations with similar potency but different metabolic cost
• align dosing systems to physiologic rhythmic tolerance

This is particularly important in therapeutic areas involving:

• mitochondrial vulnerability
• chronic inflammation
• neuroimmune instability
• long-duration treatment exposure

10. Limitations

Future refinement may incorporate phase-space modeling, redox topology, and chrono-pharmacologic weighting.

Summary

The HSV-F² metric quantifies whether a therapeutic system is not merely effective, but also energetically sustainable and harmonically compatible with biologic function. By integrating therapeutic benefit, metabolic burden, field coherence, and temporal stability, HSV-F² operationalizes the SCF principle of Metabolic Efficiency.